Oral Presentation

[29V06-pm] 循環器、呼吸器

Mon. Mar 29, 2021 3:27 PM - 5:15 PM [Room V06] Oral Presentation 6 (Online)

座長：坂本謙司（帝京大薬）、町田拓自（北医療大薬）

+Add all to schedule

3:27 PM - 3:39 PM

[29V06-pm11] Inhibitory effects of Rho kinase 2 inhibitor on excessive cell proliferation in pulmonary arterial hypertension

○Aya Yamamura¹, Nayeem Md Junayed ¹, Rie Takahashi¹, Motohiko Sato¹ (1. Dept. Physiol., Aichi Medical Univ.)

3:39 PM - 3:51 PM

[29V06-pm12S] Fingolimod improves PAH in monocrotaline-induced pulmonary hypertensive rats

○Moe Fujiwara¹, Aya Yamamura², Yoshiaki Suzuki¹, Hisao Yamamura¹ (1. Grad. Sch. Pharmaceut. Sci., Nagoya City Univ., 2. Sch. Med., Aichi Med. Univ.)

3:51 PM - 4:03 PM

[29V06-pm13S] Inhibition of ERK1/2 normalizes endothelial dysfunction by reducing eNOS-containing MPs from diabetic mice

○Nozomu Kaneko¹, Kumiko Taguchi¹, Chisaki Yoshida¹, Shiena Tanaka¹, Satoka Kase¹, Kanami Okudaira¹, Takayuki Matsumoto¹, Tsuneo Kobayashi¹ (1. Hoshi Univ.)

4:03 PM - 4:15 PM

[29V06-pm14S] GLP-1 improves the impaired insulin-induced relaxation response through β-arrestin2 regulation in diabetic mice aortas

○Kanami Okudaira¹, Kumiko Taguchi¹, Nozomu Kaneko¹, Takayuki Matsumoto¹, Tsuneo Kobayashi¹ (1. Hoshi Univ.)

4:15 PM - 4:27 PM

[29V06-pm15S] A pharmacological study on β-adrenergic receptor signalingin contractile function of human iPS cell-derived cardiomyocytes

○Wataru Kunii¹, Momoka Nakagawa¹, Gen Igarashi¹, Masahiko Yamaguchi¹, Kazuho Sakamoto¹, Junko Kurokawa¹ (1. Sch. Pharm. Sci., Univ. Shizuoka)

4:27 PM - 4:39 PM

[29V06-pm16S] Chrysanthemum morifolium extract inhibited doxorubicin-induced cardiotoxicity in vitro and in vivo

○Kanako Tsuchitani¹, Saho Mochizuki¹, Masaya Ono¹, Yoichi Sunagawa^1,3,2, Masafumi Funamoto^1,2, Kana Shimizu^1,2, Sari Nurmila¹, Satoshi Shimizu¹, Yasufumi Katanasaka^1,2,3, Yusuke Miyazki^1,2,3, Koji Hasegawa^1,2, Tatsuya Morimoto^1,2,3 (1. Sch. Pharm. Sci., Univ. of Shizuoka, 2. Kyoto Med. Ctr., NHO., 3. Shizuoka General Hosp.)

4:39 PM - 4:51 PM

[29V06-pm17S] Twenty novel compounds for heart failure therapy were identified by high throughput screening assay

○Miho Yamada¹, Yoichi Sunagawa^1,3,4, Satoshi Shimizu^2,3, Takahiro Katagiri¹, Hikaru Moki², Masafumi Funamoto^1,3, Sari Nurmila², Kana Shimizu^2,3, Yasufumi Katanasaka^1,3,4, Yusuke Miyazaki^1,3,4, Naohisa Ogo², Akira Asai², Koji Hasegawa^1,3, Tatsuya Morimoto^1,3,4 (1. Sch. Pharm. Sci., Univ. of Shizuoka, 2. Grad. Sch. Pharm. and Nutritional Sci., 3. Kyoto Med. Ctr., NHO., 4. Shizuoka General Hosp.)

4:51 PM - 5:03 PM

[29V06-pm18S] Testosterone deficiency accelerated PPE-induced pulmonary emphysema in orchiectomized mice

○Kentaro Aono¹, Yuna Sakai², Junichi Matsumoto², Taichi Matsumoto², Rina Miyoshi², Keisuke Migita², Shinya Dohgu², Atsushi Yamauchi² (1. Grad. Sch. of Pharm. Sci., Fukuoka Univ., 2. Pharm Sci., Fukuoka Univ.)

5:03 PM - 5:15 PM

[29V06-pm19S] Testosterone supplementation prevents PPE-induced pulmonary emphysema in orchiectomized mice

○Yuna Sakai¹, Kentaro Aono², Junichi Matsumoto¹, Taichi Matsumoto¹, Rina Miyoshi¹, Keisuke Migita¹, Shinya Dohgu¹, Atsushi Yamauchi¹ (1. Pharm. Sci., Fukuoka Univ., 2. Grad. Sch. of Pharm. Sci., Fukuoka Univ.)

Session information